Friday, June 14, 2024
MyDosti AD
Home Business Former Theranos exec Sunny Balwani sentenced to nearly 13 years in prison

Former Theranos exec Sunny Balwani sentenced to nearly 13 years in prison


DECEMBER 7, 2022

Sunny Balwani, former Theranos executive and romantic partner of Elizabeth Holmes, has been sentenced to nearly 13 years in prison over his role in the now-defunct blood testing firm.

The sentence is slightly longer than that given to Holmes just a few weeks ago, who was his accomplice in one of Silicon Valley’s biggest scandals.

Balwani, who was convicted in July on all 12 charges brought against him for defrauding Theranos investors and patients, is facing a maximum of 20 years in prison. His sentencing comes after co-conspirator Holmes received more than 11 years on 18 November on four charges of defrauding investors. She was acquitted on patient-related charges.

Throughout his 13-week trial, which began in March, Balwani’s lawyers painted the executive as a tireless worker who “put his money where his mouth is”, investing $15m of his own fortune into Theranos.

Prosecutors argued Balwani, who at one point oversaw the Theranos lab, steered the company along with Holmes. “I am responsible for everything at Theranos,” Balwani’s text messages shared in court said. “All have been my decisions too.”

Lawyers for Balwani had requested he receive only probation and no prison time, arguing that his personal investment losses in Theranos constituted sufficient punishment. They also argued he did not seek the “fame or media attention” that Holmes did as head of the company.

Prosecutors meanwhile urged a sentence of 15 years and $803m in restitution. They argued that through inaccurate blood tests at Theranos, Balwani had shown “conscious or reckless risk of death or serious bodily injury” toward patients and deserved a longer sentence than Holmes.

“Mr Balwani is not a victim. He is the perpetrator of the fraud,” prosecutor Jeffrey Schenk said in closing arguments for Balwani’s trial.

The sentencing of Balwani marks the latest milestone in the years-long saga of Theranos, which Holmes founded after dropping out of Stanford at 19 years old. Promising a revolutionary technology that could run hundreds of health tests on just a drop of blood, Theranos attracted big-name backers such as the former secretary of state Henry Kissinger and media mogul Rupert Murdoch.

Theranos was at one point valued at more than $9bn, but began to crumble after reporting in the Wall Street Journal in 2015 revealed shortcomings and inaccuracies in its core technology. Holmes and Balwani were charged with fraud after the company dissolved in 2018.

The outcomes of both trials have been seen as harbingers for a new era in Silicon Valley, in which companies can no longer ride unchecked hype and make false promises to secure funding.

Courtesy/Source: The Guardian